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Abstract
Background: Patients with acute exacerbation of chronic obstructive pulmonary disease (COPD)
commonly require hospitalization and admission to intensive care unit (ICU). It is useful to identify
patients at the time of admission who are likely to have poor outcome. This study was carried out
to define the predictors of mortality in patients with acute exacerbation of COPD and to device a
scoring system using the baseline physiological variables for prognosticating these patients.
Methods: Eighty-two patients with acute respiratory failure secondary to COPD admitted to
medical ICU over a one-year period were included. Clinical and demographic profile at the time of
admission to ICU including APACHE II score and Glasgow coma scale were recorded at the time
of admission to ICU. In addition, acid base disorders, renal functions, liver functions and serum
albumin, were recorded at the time of presentation. Primary outcome measure was hospital
mortality.
Results: Invasive ventilation was required in 69 patients (84.1%). Fifty-two patients survived to
hospital discharge (63.4%). APACHE II score at the time of admission to ICU {odds ratio (95 % CI):
1.32 (1.138–1.532); p < 0.001} and serum albumin (done within 24 hours of admission) {odds ratio
(95 % CI): 0.114 (0.03-0.432); p = 0.001}. An equation, constructed using the adjusted odds ratio
for the two parameters, had an area under the ROC curve of 91.3%. For the choice of cut-off,
sensitivity, specificity, positive and negative predictive value for predicting outcome was 90%,
86.5%, 79.4% and 93.7%.
Conclusion: APACHE II score at admission and SA levels with in 24 hrs after admission are
independent predictors of mortality for patients with COPD admitted to ICU. The equation
derived from these two parameters is useful for predicting outcome of these patients.
Background
Chronic obstructive pulmonary disease (COPD) is charac-
terized by irreversible airway obstruction that leads to
chronic disability. Patients with COPD have a longstand-
ing downhill course that is interspersed with episodes of
exacerbations requiring hospitalization. COPD is known
to be a common disease. There is lack of recent data
regarding the burden of this disease from India, with only
study on prevalence of COPD published in 1981 [1]. Data
from United States indicate that incidence of disease is on
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the rise [2]. During the year 2000, approximately 24 mil-
lion adults in United States had evidence of obstructive
airway disease. COPD was responsible for 1.5 million
emergency department visits, 726,000 hospitalizations,
and 119,000 deaths [2]. It is obvious that this disease puts
an enormous economic burden on the society. Andersson
and coworkers estimated that almost 35-45% of the total
per capita health-care costs for COPD are account for by
exacerbations alone [3]. Severe exacerbations requiring
hospitalizations are responsible for a large share of these
costs and among these, treatment cost for those who
require intensive care unit (ICU) admission is highest. In
most of the third world countries, large number of ICU
beds are occupied by patients with critical illnesses sec-
ondary to various infectious diseases, most of which are
reversible.
It is important to identify patients at the time of admis-
sion who are likely to have poor outcome, so that such
patients can be managed aggressively. Many prognostic
scoring systems have been devised for the same purpose.
These scoring systems help to segregate patients who are
the sickest and are likely to die from those who are
expected to have better outcome and survive. Most of
these scoring systems have been devised for a broad range
of critically ill patients. The present study was planned to
determine the predictors of mortality in patients with
exacerbation of COPD admitted to ICU over a one-year
period. An attempt was made to develop a scoring system
using the predictors of mortality that would help to iden-
tify patients at high risk of dying.
Methods
Prospectively collected data of patients with acute respira-
tory failure secondary to COPD admitted to medical ICU
of All India Institute of Medical sciences, New Delhi, India
(a tertiary care center in north India) over a one-year
period (January 2002 to December 2002) was reviewed.
Diagnosis of COPD was based upon the characteristic
findings on history and examination with typical radio-
graphic abnormalities [4]. Patients admitted to the ICU
with COPD but due to any other primary reason such as
those with poisoning or acute coronary event were
excluded. Similarly, patients in whom the primary cause
of respiratory failure was bronchiectasis, bronchial
asthma, pulmonary edema or pulmonary embolism were
not included. Finally, 82 patients with a primary admis-
sion diagnosis of acute respiratory failure secondary to
COPD were included. All patients were documented cases
with prior pulmonary function test confirmation of irre-
versible airway obstruction and had been receiving a com-
bination of various bronchodilators.
Management of the patients was the primary responsibil-
ity of the ICU team. A treatment strategy was individual-
ized for each patient and was the sole prerogative of the
treating physician. All patients received regular nebulized
bronchodilators including salbutamol (as frequently as 5
mg every 15 minutes to every 8 hours), ipratropium bro-
mide (as frequently as 0.5 mg every 15 minutes to 0.25 mg
every 8 hours), and intravenous corticosteroids. Most
patients also received antibiotics (n = 75, 91.5%). Oxygen
therapy (2-3 lt/min) was administered to spontaneously
breathing patients. The decision to institute ventilatory
support was taken by the treating physician. Wherever fea-
sible non-invasive ventilation (NIV) was used as the ini-
tial strategy. Endotracheal intubation was done for usual
indications such as respiratory arrest, deteriorating level of
consciousness, rising PaCO2 despite maximal pharmaco-
logical treatment and deteriorating acidemia. Initiation of
weaning from mechanical ventilation was considered as
soon as the patients were considered capable of breathing
spontaneously. Method of weaning trials included t-piece
trials, gradual reduction of synchronized intermittent
mandatory ventilation (SIMV) breaths and pressure sup-
port ventilation (PSV).
Clinical and demographic profile at the time of admission
to ICU including age, sex, smoking status, history of pre-
vious hospital admissions, history of previous intubation
and/or ventilatory support, prior evidence of cor pulmo-
nale with or without congestive heart failure were
recorded. Findings on clinical examination including
heart rate, respiratory rate and mean blood pressure were
recorded. Acute physiology and chronic health evaluation
II (APACHE II) score and Glasgow coma scale (GCS) were
recorded at the time of admission to the ICU. Acid-base
abnormalities at the time of presentation were analyzed
by recording the arterial blood gas analysis and serum
electrolytes (estimations done on AVL 995S). Renal func-
tions, liver functions and serum albumin (SA) done at the
time of admission were also recorded. Development of
complications during mechanical ventilator such as pneu-
mothorax and ventilator associated pneumonia (VAP)
were recorded. Development of acute respiratory distress
syndrome (ARDS), sepsis and multi-organ failure was also
documented. ARDS was defined as presence of bilateral
pulmonary infiltrates on chest radiograph in presence of
hypoxemia with PaO2 / FiO2 ratio less than 200 without
any evidence of left atrial hypertension (American-Euro-
pean Consensus Conference) [5]. Sepsis was defined as
the presence of a clinically identified site of infection (eg,
pneumonia) and two or more of the following: tempera-
ture > 38°C or < 36°C; heart rate > 90 beats/min; respira-
tory rate > 20 breaths/min or PaCO2 < 32 mm Hg; and
WBC count > 12 × 109/L, < 4.0 × 109/L, or > 0.10 imma-
ture forms (ie, bands) (American College of Chest Physi-
cians/Society of Critical Care Medicine Consensus
Conference) [6]. Days on ventilator, days of ICU stay andBMC Pulmonary Medicine 2004, 4:12 http://www.biomedcentral.com/1471-2466/4/12
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days of hospital stay were recorded for all the patients. Pri-
mary outcome measure was hospital mortality.
Statistical analysis
Data were double entered to minimize errors and man-
aged on an 'Excel' master sheet. Analysis was done using
the statistical software 'SPSS version 10.0' (SPPS Corp, Chi-
cago, IL, USA). Descriptive analysis consisted of mean
with standard deviation and range for various parameters.
Study group was split on the basis of final outcome. Vari-
ous parameters were compared between the two groups to
identify the predictors of mortality. Continuous variables
were analyzed using student's t-test whereas Fisher's exact
test was used to compare the ordinal variables. Baseline
parameters significant on univariate analysis at p < 0.1
were identified as potential predictor variables. These
parameters were evaluated using multivariate logistic
regression analysis (backward stepwise method) to deter-
mine independent predictors of mortality. An equation
was constructed using the independent predictors based
on the adjusted odds ratios and a diagnostic rule was
defined. To evaluate the predictive capability of the varia-
bles and the equation, receiver-operator characteristic
(ROC) curves were constructed with sensitivity (on X-
axis) and 1-specificity (on Y-axis) for various cut-offs. Sig-




Demographic and baseline clinical and laboratory profile
of the study group are presented in Table 1. Almost all
patients had type II respiratory failure (n = 74, 90.2%) and
showed acute on chronic respiratory acidosis. Study
cohort mostly consisted of critically ill patients as sug-
gested by a high mean APACHE II score. History of smok-
ing could be elicited in 65 patients (79.3%). A significant
number of patients had history of previous hospitaliza-
tion as well as intubation (39% and 18.3% respectively).
Almost 55% of the patients (n = 45) had evidence of
underlying cor pulmonale. Fifteen patients (18.3%) had
underlying diabetes mellitus whereas 12 patients (14.6%)
were on treatment for hypertension. None of the patients
suffered from any other co-morbid condition. An attempt
was made to define the cause of exacerbation for all
patients. There was evidence of pneumonia in 67% (n =
55) of patients whereas pneumothorax was responsible
for decompensation in 3 patients (3.7%). No obvious
cause could be found in 24 patients (29%). Only one
patient had evidence of sepsis, but none had ARDS at the
time of admission to the ICU.
Hospital course
Non Invasive Ventilation (NIV) was used as initial strategy
in 17 patients (20.7%). This strategy had a success rate of
59% (n = 10). Sixty-nine patients (84.1%) received inva-
sive ventilation (including seven patients who failed NIV
and had to be intubated). Sepsis developed in 11 patients
(13.4%) and all these patients eventually died. Parameters
associated with development of sepsis were high APACHE
II score (18 vs. 12, p = 0.005) and low SA (2.6 gm/dL% vs.
3.3 gm/dL, p < 0.001). VAP developed in 6 patients
(8.7%) and was associated with an increased stay in the
ICU (18 days vs. 10 days, p = 0.021) as well as increased
Table 1: Descriptive profile of the study group (n = 82)
Minimum Maximum Mean ± Std. Deviation
Age (years) 35 85 60 ± 10
APACHE II score 3 33 13 ± 6
PR (per minute) 46 166 105 ± 19
RR (per minute) 10 46 27 ± 10
MBP (mmHg) 20 126 89 ± 19
GCS 3 15 12.1 ± 3
pH 6.87 7.44 7.25 ± 0.19
PaCO2 (mmHg) 40.7 130.7 76.6 ± 23.5
PO2 (mmHg) 31.5 142.3 83.9 ± 41.7
HCO3 (mmHg) 5.4 55.4 32.3 ± 8.7
Serum Na (mEq/L) 115 152 136 ± 7
Serum K (mEq/L) 2.00 6.80 4.2 ± 0.9
Serum Albumin (gm%) 1.7 4.4 3.2 ± 0.7
Days on ventilator 1 33 8.7 ± 4.6
Days of ICU stay 1 35 9.6 ± 6.2
Days of hospital stay 1 63 16.3 ± 10.4
RR: Respiratory rate, PR: Pulse rate, MBP: Mean blood pressure, GCS: Glasgow coma scale, Serum Na: Serum sodium, Serum K: Serum potassium.BMC Pulmonary Medicine 2004, 4:12 http://www.biomedcentral.com/1471-2466/4/12
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stay in the hospital (30 days vs. 15 days, p = 0.005). Out-
come was not significantly affected by development of
VAP (50% versus 42.8%).
Outcome
Hospital mortality was 36.6% (n = 30). Various parame-
ters were compared for survivors and non-survivors (table
2). In addition to demographic characteristics (age and
sex), presence of cor pulmonale and cause of exacerbation
of COPD, baseline parameters significantly different
between the two groups on univariate analysis were
included in a multivariate equation. APACHE II score at
admission to the ICU {odds ratio (95 % CI): 1.32 (1.138-
1.532); p < 0.001} and SA (done within 24 hours of
admission) {odds ratio (95 % CI): 0.114 (0.03-0.432); p
= 0.001} emerged as the independent predictors of mor-
tality. ROC curve showed that both these variables have
good predictive capability with area under the ROC curve
(AUC) of 86.9% for APACHE II score (Figure 1) and
82.2% for SA (Figure 2). Best cut-off, taken as the value on
the ROC curve at the point where curve sharply angulated,
was 13.5 for APACHE II score and that for SA was 3.05
gm/dL. Following equation was determined by combin-
ing the two variables using the adjusted odd ratio: Score =
(0.278 × APACHE II score) - (2.17 × SA), where APACHE
II score is the score at the time of admission and SA (gm/
dL) is the level with in the first 24 hours. ROC curve for
this equation showed an AUC value of 91.2% (Figure 3).
We chose a cut-off of -2.97 for the equation. That is, a
patient with a score above -2.97 is likely to die whereas the
one with below -2.97 likely to survive. This diagnostic rule
had a specificity of 86.5% with a sensitivity of 90%. Posi-
tive predictive value for this variable was 79.4% whereas
negative predictive value was 93.7%. A cut-off of -0.45 was
100% specific for hospital mortality but sensitivity was
only 40%. On the other hand a cut-off of -5.5 gave a sen-
sitivity of 100% with specificity of 33%.
Discussion
Primary outcome measure of the present study was hospi-
tal mortality. Overall mortality rate was 36.6%. There was
a high incidence of need of MV (84.1%). In studies that
have taken into account all the patients with COPD
requiring hospitalization, mortality rate has been to the
tune of 6-42% [7-10]. Weiss & Hudson [11] reviewed 11
studies carried out to study outcome of patients with exac-
erbation of COPD and found the combined mortality rate
to be 20.3%. Selection bias in the inclusion of patients for
the present study precludes the generalization of these fig-
ures for patients with exacerbation of COPD requiring
hospitalization from India. Only a fraction of all the
patients with exacerbation of COPD admitted to our hos-
pital are managed in ICU. Many other patients with acute
exacerbation of COPD, especially those who do not
require ventilatory support, are managed in the wards
only. Because of this fact, by including patients who were
admitted to ICU the sickest group of patient with exacer-
bation of COPD was selected.
Various physiological parameters estimated at the time of
presentation were analyzed to find predictors of mortality.
Only two parameters, namely APACHE II score at admis-
sion to ICU and SA in the first 24 hours of admission,
were found to be independent predictors of hospital mor-
tality. The same two parameters also predicted develop-
ment of sepsis on bivariate analysis. Some of the earlier
studies have found blood gas parameters like pH [12] and
PaCO2 [13] to be useful in predicting outcome in COPD
patients, whereas others [14-16] did not. In the present
study, although PaCO2 and HCO3 were not independent
predictors of mortality they tended to be lower in patients
who died and the difference was statistically significant on
bivariate analysis. Also, mean pH was similar for the two
groups. This has not been reported in the earlier studies
and investigators in the past have mostly found high
Table 2: Predictors of mortality for patients with exacerbation of COPD
Parameter Survivors (n = 52) Non-survivors (n = 30) p value
Mean ± SD Mean ± SD
APACHE II score 10.6 ± 4.3 17.5 ± 5.7 0.001
GCS 12.8 ± 2.1 10.8 ± 3.7 0.003
MBP (mmHg) 93 ± 13.6 82.5 ± 24.7 0.015
PR (per minute) 110.7 ± 16.9 102.2 ± 21.1 0.049
Serum Albumin (gm%) 3.5 ± 0.5 2.7 ± 0.6 0.001
PaCO2 (mmHg) 81.2 ± 20.8 68.7 ± 25.8 0.018
HCO3 (mmol/L) 33.8 ± 8.1 29.6 ± 9.1 0.035
Need of reintubation 35.3% 4.4% 0.001
Renal Failure Nil 16.7% 0.002
Sepsis Nil 36.7% <0.001
GCS: Glasgow coma scale, MBP: Mean blood pressure, PR: Pulse rate.BMC Pulmonary Medicine 2004, 4:12 http://www.biomedcentral.com/1471-2466/4/12
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PaCO2 levels to be associated with worse outcome. A pos-
sible reason for this finding is that patients with hypercap-
nia with concordantly high HCO3 are usually taken care of
by mechanical ventilation. On the other hand, low mean
PaCO2  and HCO3  levels in non-survivors probably
reflected underlying metabolic acidosis. It has been
reported earlier also that, for similar level of acidosis,
patients with respiratory failure resulting in respiratory
acidosis have better outcome as compared to patients
with metabolic acidosis, that is commonly secondary to
associated non-pulmonary organ failure [17]. Mean pH
was similar for both survivors and non-survivors but sur-
vivors comprised predominantly of patients with respira-
tory acidosis (higher PaCO2 as well as HCO3) whereas
non-survivors consisted of patients with metabolic acido-
sis (lower PaCO2 and HCO3 but similar pH). Another
finding that corroborates the same fact is that all patients,
who had associated renal failure and/or sepsis, died. The
incidence of these two complications was significantly
higher in non-survivors (renal failure 16.7% vs nil, p =
0.002; sepsis 36.7% vs nil, p < 0.001). Patients with both
these complications commonly have associated meta-
bolic acidosis.
Prognostic utility of APACHE II score has been extensively
investigated. It has been found useful for prognosticating
critically ill patients across a wide array of diagnostic cate-
gories. Earlier studies have also found APACHE II score to
be useful in predicting mortality in COPD patients with
acute exacerbation [18-21] although the timing of scoring
Receiver operator characteristic (ROC) curve plotted for studying the diagnostic utility of Serum Albumin in predicting out- come of patients Figure 1
Receiver operator characteristic (ROC) curve plotted for studying the diagnostic utility of Serum Albumin in predicting out-
come of patients. The choice of cut-off is shown by an arrow (3.05 g/dL).BMC Pulmonary Medicine 2004, 4:12 http://www.biomedcentral.com/1471-2466/4/12
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after admission has varied in different studies. For exam-
ple Nevins & Epstein [18] found APACHE II score at 6 hrs
after initiation of ventilation to be a useful predictor of
mortality. In the present study, APACHE II scoring done at
the time of admission to medical ICU was analyzed. SA
estimated with in first 24 hrs of admission was also found
to be a strong predictor of mortality. SA has also been
reported to be of good prognostic value in the past [21-
23]. Utility of prognostic value of SA in patients with
COPD is interesting. Albumin has a long half-life of
approximately 18 days and because of this fact it is
unlikely to change with development of acute respiratory
failure in patients with COPD. On the other hand SA is
known to reflect the underlying nutritional status and to
be affected by the severity of chronic illness. These factors
are of obvious significance in deciding the outcome of
these patients.
An important purpose of the present study was to define
predictors, which could help to identify patients that are
likely to have worse outcome. This would help us to seg-
regate patients who need to be managed aggressively from
the very beginning. We looked at individual predictive
utility of the parameters (SA and APACHE II score) that
were found to be independent predictors of mortality.
Both these parameters had good predictive value as
evidenced by high AUC values. To improve the predictive
utility, an equation was constructed using the adjusted
odds ratio of the two parameters. ROC curve for this equa-
tion had a superior AUC value of 0.912. A good prognos-
Receiver operator characteristic (ROC) curve plotted for studying the diagnostic utility of APACHE II score in predicting out- come of patients Figure 2
Receiver operator characteristic (ROC) curve plotted for studying the diagnostic utility of APACHE II score in predicting out-
come of patients. The choice of cut-off is shown by an arrow (13.5).BMC Pulmonary Medicine 2004, 4:12 http://www.biomedcentral.com/1471-2466/4/12
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tic marker needs to be highly specific so that false
positives remain low. On the other hand, good sensitivity
is also desirable so that false negatives are not too high. A
cutoff value of -2.97 has been suggested, which is associ-
ated with good specificity (86.5%) as well as sensitivity
(90%) for predicting mortality of these patients. Cut-off
that were associated with 100% specificity and sensitivity
were also determined as different ICU's across the globe
may have different priorities at different times.
Although prospective studies are required to validate the
findings of present study, an equation devised by combi-
nation of APACHE II score and SA appears to make sense.
Estimation of APACHE II score makes use of various phys-
iological variables but does not include SA levels. Also, the
chronic physiology score in APACHE II fails to stratify
patients according to varying severity of chronic illnesses.
This tends to happen in patients with COPD as well. Use
of SA, which predominantly reflects the severity of chronic
illness, in the equation seems to complement the predic-
tive capability of APACHE II score. The results of the
present study reflect the complex interplay of factors that
occurs in patients with exacerbation of COPD. In these
patients, an acute insult in the form of exacerbating illness
develops on top of a chronic smoldering illness. Severity
of both acute insult as well as the underlying disease in the
Receiver operator characteristic (ROC) curve plotted for studying the diagnostic utility of score derived form equation in pre- dicting outcome of patients Figure 3
Receiver operator characteristic (ROC) curve plotted for studying the diagnostic utility of score derived form equation in pre-
dicting outcome of patients. The choice of cut-off is shown by an arrow (-2.97).BMC Pulmonary Medicine 2004, 4:12 http://www.biomedcentral.com/1471-2466/4/12
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background of the level of nutritional status tends to
determine the outcome of these patients.
Although the equation is useful in to identifying patients
with exacerbation of COPD who are likely to have poor
outcome, it cannot be looked at in isolation. Other partic-
ulars of these patients such as associated illnesses and co-
morbidities must be kept in mind before taking a final
decision. It cannot be overemphasized that given the sen-
sitivity and specificity of the equation, certain patients
with a score below the suggested cut-off may also be sick.
Also, the state of patients with exacerbation of COPD
tends to remain in a constant flux and need constant mon-
itoring. In spite of having a low score at presentation
many of these patients may deteriorate during hospital
stay.
It is concluded that APACHE II score at admission and SA
levels with in first 24 hrs after admission are independent
predictors of mortality for patients with exacerbation of
COPD. The equation derived by combining these two
parameters is useful for identifying patients that are likely
to have poor outcome.
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